2 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Recruiting 2, Active not recruiting 1, Completed 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children triple therapy, sequential therapy, bismuth quadruple therapy - Helicobacter Infections | Not applicable | Recruiting | Ying HUANG | 1440 | 2017-09-20 | 2025-02-28 |
| The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children Gastrus, Placebo - Helicobacter Infections | Not applicable | Withdrawn | University Medical Centre Ljubljana | 2016-01-01 | 2017-08-22 | |
| The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection H. pylori culture and antimicrobial susceptibility testing, 14 days empirical bismuth quadruple therapy (Proton pump inhibitor), Metronidazole - Helicobacter Infection | Not applicable | Terminated | Seoul National University Bundang Hospital | 370 | 2014-08-01 | 2023-04-13 |
| The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole), 7 day tailored PPI triple therapy (clarithromycin-containing triple therapy), 7 day moxifloxacin based triple therapy [Esomeprazole, Moxifloxacin, Amoxicillin] - Helicobacter Infection | Not applicable | Recruiting | Seoul National University Bundang Hospital | 600 | 2014-08-01 | 2026-04-24 |
| Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection Standard Triple Therapy, Sequential Therapy - Helicobacter Infection | Not applicable | Unknown | Dallas VA Medical Center | 184 | 2012-02-01 | 2012-11-07 |
| Helicobacter Pylori Eradication to Prevent Gastric Cancer OAC triple therapy, Placebo - Helicobacter Infections, Stomach Neoplasms | Not applicable | Active not recruiting | Jie-Jun Wang | 3000 | 2010-06-01 | 2023-10-10 |
| The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori H. pylori culture and antimicrobial susceptibility test, 14 day PBMT group, 14 day MEA group - Helicobacter Infection | Not applicable | Completed | Seoul National University Bundang Hospital | 219 | 2010-01-01 | 2016-10-04 |
Precancerous Conditions (1) · Stomach Neoplasms (1)
Bacterial Infections (7) · Bacterial Infections and Mycoses (7) · Gram-Negative Bacterial Infections (7) · Infections (7) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Stomach Diseases (1)
Amoxicillin (3) · Metronidazole (3) · Clarithromycin (2) · Moxifloxacin (2) · Esomeprazole (1) · Omeprazole (1) · Proton Pump Inhibitors (1) · Tetracycline (1) · technetium Tc 99m 1,6-di-(2-thienyl)-2,5-diazahexane (1)
Seoul National University Bundang Hospital (3) · Dallas VA Medical Center (1) · Jie-Jun Wang (1) · University Medical Centre Ljubljana (1) · Ying HUANG (1)
China (2) · South Korea (2) · Belgium (1) · Croatia (1) · Germany (1) · Israel (1) · Slovenia (1) · United States (1)
Nayoung Kim, M.D., Ph. D (3) · Byron Cryer, MD (1) · Elizabeth Coss, MD (1) · Jie J Wang, M.D. (1) · Matjaz Homan, MD PhD (1) · Robert Genta, MD (1) · Xi Wang, M.D. (1)